- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
- 3 x BR: BROMIDE ION(Non-covalent)
BR.2: 5 residues within 4Å:- Chain A: H.80, M.82, T.83
- Chain B: R.114
- Ligands: 01.11
Ligand excluded by PLIPBR.3: 6 residues within 4Å:- Chain A: W.49, I.51
- Chain B: M.28, K.29, T.30, R.174
Ligand excluded by PLIPBR.4: 6 residues within 4Å:- Chain A: R.114
- Chain B: P.79, H.80, M.82, T.83
- Ligands: 01.7
Ligand excluded by PLIP- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.5: 2 residues within 4Å:- Chain A: T.21
- Ligands: GDP.1
2 PLIP interactions:1 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:T.21, H2O.1
MG.10: 3 residues within 4Å:- Chain B: K.20, T.21
- Ligands: GDP.8
5 PLIP interactions:1 interactions with chain B, 4 Ligand-Water interactions- Metal complexes: B:T.21, H2O.1, H2O.3, H2O.3, H2O.3
- 1 x F: FLUORIDE ION(Non-covalent)
- 2 x 01: 1-{(3S)-4-[(7M)-7-[6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl]-6-chloro-8-fluoro-2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}quinazolin-4-yl]-3-methylpiperazin-1-yl}propan-1-one
01.7: 27 residues within 4Å:- Chain A: M.11, V.13, G.14, A.15, C.16, G.17, K.20, Y.88, H.106, Y.107, Q.110, I.111, R.114
- Chain B: F.68, A.69, G.70, R.71, E.72, Y.75, S.76, H.78, P.79, H.80, F.81, M.82
- Ligands: GDP.1, BR.4
9 PLIP interactions:6 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:H.106, A:Y.107, A:Y.107, A:Y.107, A:Q.110, B:Y.75
- Hydrogen bonds: A:K.20, B:E.72, B:H.78
01.11: 26 residues within 4Å:- Chain A: F.68, A.69, G.70, E.72, E.73, Y.75, S.76, P.79, H.80, F.81, M.82
- Chain B: M.11, V.13, G.14, A.15, C.16, G.17, K.20, Y.88, H.106, Y.107, Q.110, I.111, R.114
- Ligands: BR.2, GDP.8
16 PLIP interactions:6 interactions with chain A, 10 interactions with chain B- Hydrophobic interactions: A:Y.75, A:Y.75, B:Y.88, B:Y.107, B:Q.110, B:I.111
- Hydrogen bonds: A:P.79, A:M.82, B:K.20
- Salt bridges: A:E.72
- pi-Cation interactions: A:Y.75
- Water bridges: B:Q.110, B:Q.110, B:Q.110
- Halogen bonds: B:Y.107, B:Q.110
- 1 x IOD: IODIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhu, L.Y. et al., LRRK2 Roc domain RP (Ras-pocket) complexed to Divarasib. To Be Published
- Release Date
- 2024-12-11
- Peptides
- Leucine-rich repeat serine/threonine-protein kinase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)
- 3 x BR: BROMIDE ION(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- 1 x F: FLUORIDE ION(Non-covalent)
- 2 x 01: 1-{(3S)-4-[(7M)-7-[6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl]-6-chloro-8-fluoro-2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}quinazolin-4-yl]-3-methylpiperazin-1-yl}propan-1-one
- 1 x IOD: IODIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhu, L.Y. et al., LRRK2 Roc domain RP (Ras-pocket) complexed to Divarasib. To Be Published
- Release Date
- 2024-12-11
- Peptides
- Leucine-rich repeat serine/threonine-protein kinase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B